Free Trial

Citigroup Lowers Equifax (NYSE:EFX) Price Target to $238.00

Equifax logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Citigroup cut its price target on Equifax to $238 from $256 but kept a "buy" rating, while the Street consensus is a "Moderate Buy" with an average target of $231, implying meaningful upside from current levels.
  • Q1 beat but with caution: Equifax reported $1.86 EPS versus $1.69 expected and record revenue of $1.65B (up ~14%), citing AI and cloud-driven tailwinds, yet management issued cautious guidance and flagged mortgage/ macro risks.
  • Insider selling and valuation: Insiders sold about 49,671 shares (~$9.96M) last quarter (insider ownership 1.7%), and the stock trades at roughly a 36.2 P/E with a market cap near $23.2B.
  • MarketBeat previews top five stocks to own in May.

Equifax (NYSE:EFX - Get Free Report) had its price target cut by analysts at Citigroup from $256.00 to $238.00 in a research note issued on Wednesday,MarketScreener reports. The firm currently has a "buy" rating on the credit services provider's stock. Citigroup's target price would indicate a potential upside of 23.70% from the stock's previous close.

A number of other research firms have also recently commented on EFX. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Equifax in a research report on Monday, December 29th. Mizuho initiated coverage on Equifax in a research report on Thursday, April 16th. They issued an "outperform" rating and a $222.00 price target for the company. Bank of America assumed coverage on shares of Equifax in a report on Tuesday, February 17th. They set a "buy" rating and a $250.00 price objective on the stock. JPMorgan Chase & Co. decreased their price objective on Equifax from $260.00 to $230.00 and set an "overweight" rating on the stock in a report on Thursday, February 5th. Finally, Robert W. Baird reduced their target price on Equifax from $250.00 to $245.00 and set an "outperform" rating on the stock in a research note on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $231.00.

Get Our Latest Stock Report on Equifax

Equifax Stock Down 0.0%

Shares of NYSE:EFX opened at $192.41 on Wednesday. Equifax has a one year low of $166.02 and a one year high of $281.03. The company has a 50 day moving average of $189.45 and a 200-day moving average of $206.02. The company has a debt-to-equity ratio of 0.88, a current ratio of 0.60 and a quick ratio of 0.60. The stock has a market cap of $23.21 billion, a price-to-earnings ratio of 36.17, a P/E/G ratio of 1.51 and a beta of 1.56.

Equifax (NYSE:EFX - Get Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The credit services provider reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.17. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.61 billion. Equifax had a net margin of 10.87% and a return on equity of 19.27%. Equifax's revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.53 earnings per share. Equifax has set its Q2 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.340-8.740 EPS. On average, sell-side analysts forecast that Equifax will post 8.62 earnings per share for the current year.

Insider Transactions at Equifax

In other news, EVP John W. Gamble, Jr. sold 4,500 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $195.72, for a total value of $880,740.00. Following the transaction, the executive vice president owned 58,921 shares of the company's stock, valued at $11,532,018.12. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Jamil Farshchi sold 6,213 shares of the firm's stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $195.81, for a total value of $1,216,567.53. Following the completion of the transaction, the executive vice president directly owned 41,036 shares in the company, valued at $8,035,259.16. This trade represents a 13.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 49,671 shares of company stock valued at $9,960,181 over the last quarter. 1.70% of the stock is currently owned by company insiders.

Institutional Trading of Equifax

Institutional investors have recently made changes to their positions in the business. Cullen Frost Bankers Inc. purchased a new stake in shares of Equifax during the fourth quarter worth about $25,000. Ameriflex Group Inc. grew its holdings in Equifax by 612.5% during the 4th quarter. Ameriflex Group Inc. now owns 114 shares of the credit services provider's stock valued at $25,000 after buying an additional 98 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new position in Equifax during the 4th quarter valued at approximately $26,000. Reflection Asset Management purchased a new position in Equifax during the 4th quarter valued at approximately $26,000. Finally, Spire Wealth Management grew its holdings in Equifax by 82.9% during the 3rd quarter. Spire Wealth Management now owns 128 shares of the credit services provider's stock valued at $33,000 after buying an additional 58 shares in the last quarter. Hedge funds and other institutional investors own 96.20% of the company's stock.

Key Equifax News

Here are the key news stories impacting Equifax this week:

  • Positive Sentiment: Q1 beat — Equifax reported $1.86 EPS vs. $1.69 expected and record revenue of $1.649B (up ~14%), roughly $37M above the midpoint of February guidance; topline strength is a clear near‑term positive. Equifax Delivers Record First Quarter Revenue
  • Positive Sentiment: Product/AI tailwinds — Management credited AI‑driven product innovation and strong cloud adoption (including a 38% jump in U.S. mortgage revenue) for the record quarter, supporting growth expectations if execution continues. Equifax Credits AI Tools for Record $1.6 Billion Quarter
  • Positive Sentiment: Analyst support — Needham reaffirmed a Buy and set a $265 price target (meaningful upside to current levels), citing operational outperformance and disciplined buybacks. That endorsement may underpin buyer interest. Needham Reaffirms Buy on Equifax
  • Neutral Sentiment: Earnings call tone mixed — The call highlighted growth and strategic initiatives but management struck a cautious tone on the mortgage outlook and macro, making the beat less unambiguously bullish. Earnings Call: Growth, Caution And Cash
  • Negative Sentiment: Cautious guidance and mortgage risk — Equifax maintained FY and Q2 guidance that sits around or slightly below consensus (Q2 EPS 2.15–2.25 vs. est. ~2.24; FY EPS 8.34–8.74 vs. est. ~8.60). Management flagged Iran‑related rate moves and potential mortgage market weakness, which prompted profit‑taking. Equifax stock slips after maintaining revenue guidance
  • Negative Sentiment: Analyst PT trim — Jefferies cut its price target from $240 to $220 (still a Buy), signaling some analyst caution on the near‑term outlook; incremental PT downgrades could weigh on sentiment. Jefferies Lowers PT on Equifax

Equifax Company Profile

(Get Free Report)

Equifax Inc NYSE: EFX is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company's offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.

Read More

Analyst Recommendations for Equifax (NYSE:EFX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines